S. Savitha

S. Savitha

Auto-generated profile, based on publicly available information

S. Savitha

K.S.R. College of Engineering, India

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2025
Verified
Book Chapter
Closed access
SSS. Savitha
S. Savitha
RKR. Keerthana
R. Keerthana
KLK. Logeswaran
K. Logeswaran
PKP. Keerthika
P. Keerthika
VSV. Sharmila
V. Sharmila
MSM. Sangeetha
M. Sangeetha
Integrating multi-omics data, such as proteomics, metabolomics, and genomes, in precision health provides revolutionary insights into biological systems and individualized treatment plans. This chapter focuses on AI-powered techniques for merging multi-omics data, made possible by high-throughput instruments such as next-generation sequencing and mass spectrometry. Single-omic techniques, which frequently overlook intricate molecular interactions essential to comprehending the etiology of disease, are outperformed by multi-omics integration. By capturing non-linear relationships and hierarchical characteristics across genes, proteins, and metabolites, artificial intelligence (AI) techniques—including deep learning models like CNNs and RNNs—increase multi-omics analysis and improve illness treatment and prediction. Federated Multi-Modal Embedding Networks (FMEN) promote precision models across omics types by advancing multi-omics integration through collaborative learning while protecting data privacy.

23 April 2025
Verified
Book Chapter
Closed access
SSS. Savitha
S. Savitha
RKR. Keerthana
R. Keerthana
KLK. Logeswaran
K. Logeswaran
VVV. Vennila
V. Vennila
RMR. Manjuladevi
R. Manjuladevi
MSM. Sangeetha
M. Sangeetha
Artificial intelligence (AI) has transformed early disease diagnosis, providing exceptional speed and accuracy. However, fairness and bias challenges remain in healthcare AI, leading to discriminatory outcomes and worsening existing health inequities. These biases often arise from data imbalances, model architecture, and decision-making processes, with socioeconomic factors exacerbating historical disparities. Curating inclusive datasets with diverse demographic and socioeconomic representation is essential. Techniques like adversarial debiasing and data augmentation improve equity, while algorithmic fairness methods, such as regularization and fairness constraints, ensure equitable treatment. Differential privacy protects sensitive attributes, and ensemble methods like fairness-aware boosting uphold accuracy. Ongoing innovation is crucial for developing transparent, fair, and accurate AI systems in healthcare.

13 May 2025
Verified
Book Chapter
Closed access
RKR. Keerthana
R. Keerthana
SSS. Savitha
S. Savitha
KLK. Logeswaran
K. Logeswaran
ARA. Rajivkannan
A. Rajivkannan
MNM. Namasivayam
M. Namasivayam
AI improves immune disease prediction by examining clinical and genomic information to determine biomarkers, enhance diagnoses, individualize treatment, and predict outcomes. Challenges include scarce high-quality data, integrating genomic and environmental variables, privacy legislation, bias, and deep learning transparency lowering clinician confidence. Federated learning maintains privacy but grapples with data quality, and explainable AI (XAI) assists interpretability but remains clinically irrelevant. SVMs, RF, CNNs, and RNNs are AI models that help in disease tracking and diagnosis. Clustering and Bayesian networks evaluate risks. Maximizing the potential of AI requires enhancing data quality, model interpretability, and clinician-data scientist collaboration to improve immunological disorder prediction.

22 April 2024
Verified
Book Chapter
Closed access
VHV. Hemamalini
V. Hemamalini
MJM. Jeyaselvi
M. Jeyaselvi
SSS. Savitha
S. Savitha
ATAmit Tyagi
Amit Tyagi
This chapter examines the current landscape and future prospects of emerging technologies in drug discovery, focusing on their potential to provide efficient and innovative services to patients. The integration of technologies such as artificial intelligence (AI), machine learning, high-throughput screening, and advanced analytics is reshaping the drug discovery process, promising accelerated development timelines and improved therapeutic outcomes. AI and machine learning algorithms play a pivotal role in data analysis, aiding in the identification of potential drug candidates, target validation, and predictive modeling. High-throughput screening technologies enable the rapid testing of large compound libraries, expediting the identification of lead compounds and optimizing drug development pipelines. Additionally, advanced analytics facilitate the interpretation of complex biological data, enhancing our understanding of disease mechanisms and drug interactions. The convergence of these technologies holds immense promise for personalized medicine.

3 April 2026
Verified
Book Chapter
Closed access
SSS. Savitha
S. Savitha
SHS. Hemalatha
S. Hemalatha
USU. Sathya
U. Sathya
JRJ. Rameshkumar
J. Rameshkumar
THT. Haritha
T. Haritha
RKR. Keerthana
R. Keerthana
Modern healthcare depends on quick diagnoses, secure sharing of medical information, and smooth coordination among hospitals and research institutions. However, traditional computing systems often struggle to manage large and complex clinical data, advanced medical images, and collaboration across multiple organizations. Quantum computing, when combined with e-collaboration platforms, can overcome these challenges by delivering faster analysis, stronger security, and more scalable clinical intelligence. Core quantum principles such as superposition and entanglement—support parallel data processing, rapid optimization, and improved pattern detection in genomics, medical imaging, and continuous patient monitoring. Quantum-enabled backends can strengthen digital collaboration by supporting remote consultations, shared clinical reviews, and coordinated care. Secure communication, privacy-preserving analytics, biomedical simulation, and public-health preparedness are discussed, along with current limitations and future directions.